Results 1 to 10 of about 2,566,421 (110)

Analytical validation of the 7-gene biosignature for prediction of recurrence risk and radiation therapy benefit for breast ductal carcinoma in situ

Frontiers in Oncology, 2023
Purpose Ductal carcinoma in situ (DCIS), is a noninvasive breast cancer, representing 20-25% of breast cancer diagnoses in the USA. Current treatment options for DCIS include mastectomy or breast-conserving surgery (BCS) with or without radiation therapy
D. Dabbs, Karuna Mittal, Scott Heineman, P. Whitworth, C. Shah, J. Savala, S. Shivers, T. Bremer   +7 more
semanticscholar   +1 more source

Ductal carcinoma in situ

, 2012
Ductal carcinoma in situ (DCIS) represents a spectrum of abnormal cells confined to the breast and is a risk factor for invasive cancer development. The incidence has increased dramatically in recent years as a result of widespread use of screening mammography.
Henry Knipe, Garth Kruger
  +6 more sources

Ductal Carcinoma in Situ: State-of-the-Art Review.

Radiology, 2021
Ductal carcinoma in situ (DCIS) is a nonobligate precursor of invasive cancer, and its detection, diagnosis, and management are controversial. DCIS incidence grew with the expansion of screening mammography programs in the 1980s and 1990s, and DCIS is ...
Lars J. Grimm, H. Rahbar, Monica Abdelmalak, A. Hall, M. Ryser   +4 more
semanticscholar   +1 more source

Application of deep learning to identify ductal carcinoma in situ and microinvasion of the breast using ultrasound imaging

Quantitative Imaging in Medicine and Surgery, 2022
Background The treatment and prognosis of breast ductal carcinoma in situ (DCIS) with and without microinvasion (MIC) are different. Ultrasound imaging shows that DCIS is a heterogeneous breast tumor with diverse manifestations.
Meng Zhu, Y. Pi, Zekun Jiang, Yan-Huan Wu, H. Bu, J. Bao, Yujuan Chen, Lijun Zhao, Yulan Peng   +8 more
semanticscholar   +1 more source

Prediction of the histologic upgrade of ductal carcinoma in situ using a combined radiomics and machine learning approach based on breast dynamic contrast-enhanced magnetic resonance imaging

Frontiers in Oncology, 2022
Objective To investigate whether support vector machine (SVM) trained with radiomics features based on breast magnetic resonance imaging (MRI) could predict the upgrade of ductal carcinoma in situ (DCIS) diagnosed by core needle biopsy (CNB) after ...
Hyo-jae Lee, Jae Hyeok Park, A. Nguyen, L. Do, M. Park, J. Lee, I. Park, H. Lim   +7 more
semanticscholar   +1 more source

Ductal Carcinoma in Situ [PDF]

Cancer Investigation, 1992
4. Meijers WH, Willemse PH, Sleijfer DT, i&lder NH, Grond J. Hepatocellular damage by cyproterone acetate. J Cancer Clin Oncol 1986,22,1121-1122. 5. Kaiser E, Gruner HS. Liver structure and function during long term treatment with cyproterone acetate. Arch Gynecol 1987, 240, 217-223. 6. Levesque H, Manchon ND, Moore H, et al. Fuhninant hepatitis due to
  +9 more sources

Multiple Metastases of the Liver and Lung After Breast-Conserving Surgery for Ductal Carcinoma In Situ Without Microinvasion of the Breast: A Case Report and Literature Review

Frontiers in Oncology, 2022
Background Ductal carcinoma in situ (DCIS) is a non-invasive disease that rarely causes distant metastasis. It is extremely rare for patients diagnosed with DCIS without microinvasion to develop distant metastasis in the absence of ipsilateral or ...
Zhen Wang, Xinyan Zhang, Hui Ren, Lei Zhang, Bo Chen   +4 more
semanticscholar   +1 more source

Apparent Diffusion Coefficient-Based Convolutional Neural Network Model Can Be Better Than Sole Diffusion-Weighted Magnetic Resonance Imaging to Improve the Differentiation of Invasive Breast Cancer From Breast Ductal Carcinoma In Situ

Frontiers in Oncology, 2022
Background and Purpose Breast ductal carcinoma in situ (DCIS) has no metastatic potential, and has better clinical outcomes compared with invasive breast cancer (IBC).
Haolin Yin, Yu Jiang, Zihan Xu, Wenjun Huang, Tianwu Chen, Guangwu Lin   +5 more
semanticscholar   +1 more source

Ductal Carcinoma In Situ of the Breast [PDF]

International Journal of Surgical Oncology, 2012
Ductal carcinoma in situ (DCIS) of the breast represents a complex, heterogeneous pathologic condition in which malignant epithelial cells are confined within the ducts of the breast without evidence of invasion. The increased use of screening mammography has led to a significant shift in the diagnosis of DCIS, accounting for approximately 27% of all ...
Richard J. Lee, Jennifer L. Peterson, Sarah A. McLaughlin, Stephanie L. Hines, Laura A. Vallow, Katherine S. Tzou   +5 more
openaire   +6 more sources

Case Report: Mucocele-Like Tumor of the Breast Associated With Ductal Carcinoma In Situ

Frontiers in Oncology, 2022
Mucocele-like tumor of the breast is histologically characterized as mucin-containing cysts with mucin leaking to the stroma. It could be associated with atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS), and invasive ductal carcinoma ...
Ying Jiang, L. Chai, D. Dong, A. Chughtai, Weifang Kong   +4 more
semanticscholar   +1 more source